Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Express Scripts
Julphar
Chinese Patent Office
QuintilesIMS
Novartis
Covington
Accenture
Mallinckrodt
Cantor Fitzgerald

Generated: February 24, 2018

DrugPatentWatch Database Preview

COSYNTROPIN Drug Profile

« Back to Dashboard

When do Cosyntropin patents expire, and what generic alternatives are available?

Cosyntropin is a drug marketed by Mylan Institutional, Sandoz, and Sandoz Inc. and is included in three NDAs.

The generic ingredient in COSYNTROPIN is cosyntropin. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cosyntropin profile page.
Drug patent expirations by year for COSYNTROPIN
Pharmacology for COSYNTROPIN
Medical Subject Heading (MeSH) Categories for COSYNTROPIN

US Patents and Regulatory Information for COSYNTROPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional COSYNTROPIN cosyntropin INJECTABLE;INJECTION 090574-001 Dec 17, 2009 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz COSYNTROPIN cosyntropin INJECTABLE;INJECTION 202147-001 Jun 29, 2012 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc COSYNTROPIN cosyntropin SOLUTION;INTRAVENOUS 022028-001 Feb 21, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Healthtrust
Chubb
Queensland Health
Moodys
Chinese Patent Office
Accenture
US Department of Justice
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot